• Mithra announces Donesta® phase III clinical program update

    Thursday April 2nd 2020

  • Kris Sterkens wordt nieuwe CEO van Janssen Pharmaceutica

    Wednesday April 1st 2020

  • Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

    Tuesday March 31st 2020

  • Biocartis kondigt co-commercialisatie aan van de SeptiCyte® RAPID Test op Idylla™ (CE-IVD) en brengt update over COVID-19 impact

    Friday March 27th 2020

  • Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

    Friday March 27th 2020

  • miDiagnostics raises €14m to accelerate the commercialization of its disruptive, lab-quality silicon chip diagnostics platform

    Thursday March 26th 2020

  • University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    Wednesday March 25th 2020

  • ECCRT enters into an agreement with Qualitis for continuous online development of its staff

    Wednesday March 25th 2020

  • Your news here?

  • eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

    Tuesday March 24th 2020

  • Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

    Tuesday March 24th 2020

  • Dr. Matthias Friebe joins Camel-IDS as acting Chief Technology Officer.

    Tuesday March 24th 2020


Strategic Partners